文献速递呼吸危重症与机械通气间质性肺疾病

ARDS中的肺修复与再生:PECAM1与Wnt信号通路的作用

Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling.
PubMed 文献 · Chest · 2018-10-28

本文综述急性呼吸窘迫综合征(ARDS)的分子病理机制及潜在药物治疗靶点。ARDS以肺泡-毛细血管膜屏障破坏、血管通透性增加和蛋白性水肿为特征,住院死亡率约40%,目前无特异性药物治疗。综述聚焦血小板-内皮细胞黏附分子-1(PECAM1)在维持和恢复血管完整性中的作用,以及Wnt信号通路在肺愈合与纤维化中的核心机制。

要点

  • ARDS住院死亡率约40%,目前仅有支持治疗,无特异性药物。
  • PECAM1参与屏障破坏后血管完整性的维持与恢复。
  • Wnt信号通路是肺愈合及纤维化发展的核心机制。

核心结论

  • PECAM1和Wnt信号通路是ARDS肺修复与再生及纤维化发展的潜在分子靶点。

研究设计与样本

  • 综述,总结ARDS分子损伤机制及潜在药物干预新进展。

主要发现

  • ARDS病理涉及免疫细胞浸润、细胞因子风暴、肺泡-毛细血管屏障破坏、细胞凋亡和纤维化发展等多机制交互。
  • PECAM1有助于屏障破坏后血管完整性的维持和恢复。
  • Wnt信号通路似乎是肺愈合及纤维化发展的核心机制。

关键数值与推荐

  • 多数系列报道ARDS总体住院死亡率约40%。
  • ARDS为急性炎症性肺部过程,由严重肺部和全身性打击触发肺泡-毛细血管膜损伤。
  • 支持治疗包括肺保护性通气策略,可减少呼吸功、改善氧合并最小化呼吸机诱导肺损伤。

临床怎么用

  • 对ARDS患者应使用肺保护性通气策略作为支持治疗基础。
  • PECAM1和Wnt信号通路可作为未来药物干预研究的候选靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ARDS is an acute inflammatory pulmonary process triggered by severe pulmonary and systemic insults to the alveolar-capillary membrane. This causes increased vascular permeability and the development of interstitial and alveolar protein-rich edema, leading to acute hypoxemic respiratory failure. Supportive treatment includes the use of lung-protective ventilatory strategies that decrease the work of breathing, can improve oxygenation, and minimize ventilator-induced lung injury. Despite substantial advances in supportive measures, there are no specific pharmacologic treatments for ARDS, and the overall hospital mortality rate remains about 40% in most series. The pathophysiology of ARDS involves interactions among multiple mechanisms, including immune cell infiltration, cytokine storm, alveolar-capillary barrier disruption, cell apoptosis, and the development of fibrosis. Here we review some new developments in the molecular basis of lung injury, with a focus on possible novel pharmacologic interventions aimed at improving the outcomes of patients with ARDS. Our focus is on platelet-endothelial cell adhesion molecule-1, which contributes to the maintenance and restoration of vascular integrity following barrier disruption. We also highlight the wingless-related integration site signaling pathway, which appears to be a central mechanism for lung healing as well as for fibrotic development.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Villar J, Zhang H, Slutsky AS, et al. Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling. Chest. 2018. PMID: 30392791. doi:10.1016/j.chest.2018.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。